This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29:4417–23.
Laribi K, Sobh M, Ghez D, Baugier de Materre A. Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review. Ann Hematol. 2021;100:1359–76.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;6:649–55.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.
Cohen’s Kappa Statistic. 2017. https://www.statisticshowto.datasciencecentral.com/cohens-kappa-statistic.
Ziai A. Inter-rater agreement Kappas. Towards data science. 2017. https://towardsdatascience.com/inter-rater-agreement-kappas-69cd8b91ff75.
Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131:515–24.
Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, et al. Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. J Geriatr Oncol. 2020;11:410–6.
Author information
Authors and Affiliations
Contributions
NM was responsible for data collection, data analysis, and writing the report. CS contributed to data collection. RBW and MEMP interpreted results and provided feedback on the report. EHE conceived of the project and provided critical analysis and feedback on the report: we continue to miss his knowledge and leadership in the field of AML.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mostofi, N., Shaw, C., Walter, R.B. et al. Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients. Leukemia 36, 2528–2530 (2022). https://doi.org/10.1038/s41375-022-01664-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-022-01664-4